Journal Information
Vol. 1. Issue 6.
Pages 497-504 (November - December 1995)
Share
Share
Download PDF
More article options
Vol. 1. Issue 6.
Pages 497-504 (November - December 1995)
ARTIGO ORIGINAL
Open Access
Anticorpos anti-VIH1 e VIH2 em doentes com Tuberculose. Experiência de um trabalho realizado ao longo de 3 anos nas regiões de Lisboa, Barreiro e Santarém
Visits
5360
L. Telo*, M.J. Marques Gomes*, F. Avillez**, A.P. Faria**, J.M. Carvalho*, A. Saraiva*, M. Villar*, M.L. Fonseca Santos*, F. Telhada*, A. Manique*
* Comissão de Tuberculose da Sociedade Portuguesa de Pneumologia. Lisboa
** Laboratório de Referência da SIDA do Instituto Nacional de Saúde. Lisboa
This item has received

Under a Creative Commons license
Article information
RESUMO

Pretendemos avaliar a taxa de anticorpos anti-VIH1 e anti-ViH2 em doentes com Tuberculose activa. A pesquisa de anticorpos foi realizada por ELISA e confirmada por Western Blot.

Incluímos 767 doentes (479 homens e 288 mulheres); 671 eram caucasianos, 76 negros e 20 de outras raças. Dezoito usavam drogas ilícitas por via endovenosa, 35 referiam ter feito transfusões de sangue fresco e 630 eram heterossexuais. Cento e cinquenta e três doentes tinham vivido em África por períodos variáveis de tempo; 541 doentes (70,5%) tinham Tuberculose pulmonar, 164 (21,4%) tinham Tuberculose extrapulmonar, 44 (5,7%) tinham simultaneamente Tuberculose pulmonar e extrapulmonar, sendo 12 formas miliares e 18 (2,3%) tinham Tuberculose primária.

Identificaram-se anticorpos anti-VIH em 14 doentes (1,8%): 10 anti­VIHl e 4 anti-VIH2; todos os doentes seropositivos eram heterossexuais e um toxicodependente; 5 doentes tinham exclusivamente Tuberculose pulmonar e 9 tiobam localizações extrapulmonares (entre estes, estavam todos os doentes com anticorpos anti-VIH2).

Encontrámos uma prevalência na nossa população de 1,8%, que foi mais elevada na raça negra (3,9%); a seropositividade foi mais frequente nos doentes com Tuberculose extrapulmonar. É aconselhável a pesquisa sistemática de anticorpos anti-VIH nos doentes com Tuberculose em actividade.

Palavras-chave:
SIDA
VIH
VIH1
VIH2
Tuberculose
seropositividade epidemiologia
ABSTRACT
Setting

Patients with active tuberculosis.

Objective

To evaluate the rates of anti-HIV1 and anti-HIV2 antibodies in patients with active Tuberculosis.

Design

Anti-HIV antibodies, were searched by ELISA and confirmed by Western blot.

Results

We studied 767 patients (479 men and 288 women); 671 of them were caucasian, 76 black and 20 from other races. Eighteen of them were intravenous-drug users (IVDU), 35 had been transfused, 630 were heterosexual and in 121 we didn’t obtain data about sexual behaviour; 153 sojourned in Africa for different periods of time; 541 patients (70.5%) had pulmonary tuberculosis, 164 (21.4%) had extrapulmonary tuberculosis, 44 (5,7%) patients presented pulmonary and extrapulmonary tuberculosis and 18 (2.3%) had primary tuberculosis. Fourteen (1.8%) patients bad anti-HIV antibodies: 10 HIV1 and 4 HIV2; all seropositive were heterosexual, one being IVDU; 5 had pulmonary tuberculosis and 9 had extra-pulmonary tuberculosis (including all 4 cases with HIV2).

Conclusions

We found a rate in our population of 1.8% particularly in black patients (3.9%); serum positivity was more frequent in patients with extrapulmonary tuberculosis particularly in HIV2 patients. We advise for systematic screening.

Key-words:
AIDS
HIV
Tuberculosis
seropositivity
anti-HIV1 antibodies
anti-HIV2 antibodies
Full text is only aviable in PDF
REFERÊNCIAS
[1.]
R.E. Chaisson, G.F. Schecter, C.P. Theuer, G.W. Ruther­ Ford, D.F. Echenberg, P.C. Hopewell.
Tuberculosis in patients with the Acquired Immunodeficiency Syndrome. Clinical features, response to therapy and survival.
Am. Rev. Respir. Dis, 136 (1987), pp. 570
[2.]
J. Mann.
Global AIDS: Epidemiology, impact, projections, global strategy.
Pergamon Press, (1988), pp. 3
[3.]
J.F. Murray, S.M. Garay, P.C. Hopewell, J. Mills, G.L. Snider, D.E. Stover.
Pulmonary complications of the Acquired Immunodeficiency Syndrome: an update. Report on the Second National Heart, Lung and Blood Institute Workshop.
Am. Rev. Respir. Dis., 135 (1987), pp. 504
[4.]
J.F. Murray, J. Mills.
Pulmonary infections complications of Human Immunodeficiency Virus infection. Part I.
Am Rev. Respir. Dis., 141 (1990),
[5.]
J.F. Murray.
An emerging global programme against tuberculosis: agenda for research, including the impact of HIV infection.
Bull. I.U.A.T.L.D., 66 (1991), pp. 207-209
[6.]
A.E. Pitchnik, C. Cole, B.W. Russel, M.A. Fischl, T.J. Spira, D.E.J.R. Snider.
Tuberculosis, atypical mycobacteriosis and the Acquired Immunodeficiency Syndrome among Haitian and non-Haitian pattents in South Florida.
Annals Int. Med, 101 (1984), pp. 6411
[7.]
P.A. Selwynn, D. Hartel, V.A. Lewis.
A prospective study of the risk of tuberculosis among intravenous drug users with HIV infection.
N. Engl. J. Med, 320 (1989), pp. 545
[8.]
Styblok.
Tuberculosis and HIV infection.
Bull I U.A.T.L.D., 65 (1990), pp. 28
[9.]
J.P. Narain, M.C. Raviglione, A. Kochi.
HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention.
Tubercle and Lung Disease, 73 (1992), pp. 311
[10.]
P. Sudre, G. Ten DAM, A. Kochi.
La tuberculose aujourd’hui dans le monde.
Bull. OMS, 70 (1992), pp. 297
[11.]
R.L. Colebunders, R.W. Ryder, N. Nzilambi, et al.
HIV infection in patients with tuberculosis in Kinshasa.
Zaire. Am. Rev. Respir Dis, 139 (1989), pp. 1082
[12.]
A.M. Elliot, N. Luo, G. Tembo, et al.
Impact of HIV on tuberculosis in Zambia: a cross sectional study.
BML, 301 (1990), pp. 412
[13.]
P.P. Eriki, A. Okwera, T. Aisu, et al.
The influence of human immunodeficiency virus infection on tuberculosis in Kampala Uganda.
Am. Rev. Respir. Dis, 143 (1991), pp. 185
[14.]
R. Long, M. Scalcini, J. Manfreda.
Impact of human immunodeficiency virus type 1 on tuberculosis in rural Haiti.
Am. Rev. Respir. Dis, 143 (1991), pp. 69
[15.]
Direcção Geral Dos Cuidados Primarios De Saúde/Serviços De Tuberculose E Doenças Respiratórias.
Tuberculose em Portugal, (1992),
[16.]
Centro De Vigilància Epidemiológica De Doenças Transmissiveis.
[17.]
M.J.M. Gomes, L. Telo, F. Avillez, A.P. Faria, J.M. Carvalho, A. Manique, M.L.F. Santos, A. Saraiva, M.F. Telhada.
Prevalência de anticorpos anti-HIV1 e anti-HIV2 em doentes com tuberculose.
Arquivos da Sociedade Portuguesa de Patologia Respiratória, X (1993), pp. 117
[18.]
L. Cunha Teles, D. Guerreiro, M.H. Lourenço, M.O. Santos Ferreira, R.M. Victorino.
Analise da seroprevalência da infecção pelo HIV-1 e HIV-2 em mulheres residentes numa área da cidade de Lisboa.
Acta Médica, 4 (1991), pp. 64-70
[19.]
F. Avillez.
Personal comunication.
(1992),
[20.]
F. Avillez.
Personal comunication.
(1992),
[21.]
F. Avillez, A. Benito-Garcia, A. Prista, H. Gonçalves, L. Ayres.
[22.]
A. Benito-Garcia, H. Gonçalves, A. Prista, C. Furtado, E. Padua, L. Ayres, F. Avillez.
HIV-2 in Portugal: situation in 1990.
Copyright © 1995. Sociedade Portuguesa de Pneumologia/SPP
Pulmonology
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?